Corbus Pharmaceuticals Hldgs Inc (CRBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 648 | 658 | 1,231 | 286 | 1,762 |
| Gross Profit | 648 | 658 | 1,231 | 286 | 1,762 |
| Operating Expenses | 16,062 | 21,471 | 35,205 | 38,425 | 31,647 |
| Operating Income | -15,414 | -20,812 | -33,974 | -38,139 | -29,885 |
| Other Income | -651 | 12,200 | -922 | 33 | 229 |
| Pre-tax Income | -16,065 | -8,612 | -34,895 | -38,105 | -29,657 |
| Net Income Continuous | -16,065 | -8,612 | -34,895 | -38,105 | -29,657 |
| Net Income | $-16,065 | $-8,612 | $-34,895 | $-38,105 | $-29,657 |
| EPS Basic Total Ops | -4.20 | -1.20 | -12.91 | -15.62 | -12.91 |
| EPS Basic Continuous Ops | -4.15 | -1.62 | -12.80 | -15.49 | -12.86 |
| EPS Diluted Total Ops | -4.20 | -1.20 | -12.91 | -15.62 | -12.91 |
| EPS Diluted Continuous Ops | -4.15 | -1.62 | -12.80 | -15.49 | -12.86 |
| EBITDA(a) | $-14,820 | $-20,210 | $-33,510 | $-37,678 | $-29,427 |